Arvinas Inc. share price logo

Arvinas Inc.

NASDAQ: ARVN

Small Cap

$8.03

-0.27

(-3.25%)

as on

Arvinas Inc. Stock Performance

as on August 1, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.89
    $8.17
    downward going graph

    1.74%

    Downside

    1.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.06
    $14.51
    downward going graph

    24.60%

    Downside

    80.70%

    Upside

    downward going graph

Arvinas Inc. share price movements today

Previous Close
$8.30
Open
$8.17
Volume
576.1K
Day's Low - High
$7.89 - $8.17
52 Week Low - High
$6.06 - $14.51

Arvinas Inc. Historical Returns

1 Month Return
-2.07 %
3 Month Return
-23.6 %
1 Year Return
+ 8.22 %
3 Year Return
-67.7 %
5 Year Return
-92.06 %

Arvinas Inc. Stock Fundamentals & Key Indicators

Check Arvinas Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$535.5M

EPS (TTM)

-2.8517

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-246.5M

Revenue (TTM)

89.4M

Profit Margin

-247.54%

Return On Equity TTM

-42.28%

Arvinas Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arvinas Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Arvinas Inc. image
Arvinas Inc.
BUY$535.5M-92.06%NA-247.54%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$40.9B554.78%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$122.3B136.68%28.6635.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$76.0B32.72%16.9829.65%NA

Stock Returns calculator for Arvinas Inc. Stock including INR - Dollar returns

The Arvinas Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arvinas Inc. investment value today

Current value as on today

₹1,17,935

Returns

₹17,935

(+17.94%)

Returns from Arvinas Inc. Stock

₹8,221 (+8.22%)

Dollar Impact

₹9,714 (+9.71%)

Analyst Recommendation on Arvinas Inc. Stock

Based on 26 analysts

BUY

88.46%

Buy

11.54%

Hold

0.00%

Sell

Based on 26 analysts, 88.46% of analysts recommend a 'BUY' rating for Arvinas Inc.. Average target price of $14.79

Arvinas Inc. Share Price Target

Get share price movements and forecasts by analysts on Arvinas Inc..

What analysts predicted

45.71%UPSIDE

Target Price

$14.79

Current Price

$8.03

Analyzed by

26 Analysts

Target

$14.79

Arvinas Inc. target price $14.79, a slight upside of 45.71% compared to current price of $8.03. According to 26 analysts rating.

Indian Investors' Interest in Arvinas Inc. Stock

Search interest for Arvinas Inc. Stock has decreased by -1% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-1% versus previous 30 day period

Arvinas Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-43
25
76
102
59
188
22
41
9
15
Gross Profit
-44
23
74
102
59
188
22
41
8
14
Operating Income
-165
-83
-48
-60
-58
71
-71
-43
-71
-62
EBITDA
-151
-67
-33
-47
-43
84
-60
-34
-66
-56
Interest Expense
7
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-153
-69
-35
-48
-45
83
-61
-34
-67
-57
Income Tax Expense
1
0
0
0
0
0
0
0
0
0
Net Income
-154
-69
-35
-49
-45
82
-61
-35
-67
-57
Net Profit Margin
359.16%
-274.31%
-46.01%
-48.05%
-76.18%
43.91%
-273.21%
-83.77%
-709.47%
-369.23%

Arvinas Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
7
14
42
21
46
131
78
263
262
Gross Profit
6
7
14
42
21
46
131
78
263
257
Operating Income
-16
-24
-43
-51
-124
-195
-263
-401
-250
-114
EBITDA
-13
-23
-43
-49
-120
-189
-255
-359
-191
-75
Interest Expense
0
0
0
0
0
0
12
-
-
-
Depreciation
-
0
0
2
4
6
8
7
6
5
Income Before Tax
-14
-24
-41
-70
-119
-191
-251
-366
-198
-80
Income Tax Expense
0
0
2
-8
-7
-7
20
0
0
0
Net Income
-14
-24
-41
-62
-111
-183
-271
-367
-198
-80
Net Profit Margin
-215.18%
-317.32%
-289.59%
-144.57%
-512.74%
-392.29%
-206.93%
-467.90%
-75.51%
-30.77%

Arvinas Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-69
-35
-49
-45
82
-61
-35
-67
-57
Operating Cash Flow
-97
50
-128
-84
-88
-95
-59
-30
-69
Investing Cash Flow
-127
13
50
98
69
128
63
145
13
Financing Cash Flow
1
3
2
0
0
0
-17
-74
0
Change in Cash
-223
66
-75
15
-19
33
-13
41
-55

Arvinas Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-41
-70
-119
-191
-282
-367
-198
-80
Operating Cash Flow
5
-16
-40
-89
559
-273
-347
-259
-273
Investing Cash Flow
20
-179
-93
164
-1,313
242
203
34
407
Financing Cash Flow
0
168
139
504
278
4
374
7
-91
Change in Cash
25
-27
6
579
-475
-26
230
-216
42

Global Institutional Holdings in Arvinas Inc.

Funds
Holdings
D. E. Shaw & Co LP
5.64%
Pfizer Inc
5.36%
Northern Trust Corp
0.85%
Nextech Invest, Ltd.
0.84%
Logos Global Management LP
8.72%
See all

Arvinas Inc. News & Key Events

  • img

    Today's Timeline - 13 May

    Wed, 11:24 PM

    -

    Arvinas reports Q1 losses of 90 cents per share, missing estimates; shares rise 1.7% to $9.74.

Insights on Arvinas Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -67.39M → -57.6M (in $), with an average increase of 17.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 9.50M → 15.6M (in $), with an average increase of 39.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 403.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 495.3% return, outperforming this stock by 563.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ARVN stock has moved down by -23.6%

About Arvinas Inc.

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical development programs , including ARV-102, a leucine-rich repeat kinase 2 (LRRK2) protein for the treatment of neurodegenerative diseases, such as Parkinson's disease and progressive supranuclear palsy; ARV-806, a Kirsten rat sarcoma, G12D protein for the treatment of cancers with the G12D mutation, comprising pancreatic, colorectal, and non-small cell lung cancer; ARV-393, a B-cell lymphoma 6 protein for the treatment of relapsed/refractory non-Hodgkin lymphoma (NHL); ARV-027, a polyglutamine-expanded androgen receptor in skeletal muscle; and vepdegestrant, an estrogen receptor for the treatment of locally advanced or metastatic ER+/HER2- breast cancer. In addition, the company develops Bavdegalutamide (ARV-110) and Luxdegalutamide (ARV-766), investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer. It has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
OrganisationArvinas Inc.
Headquarters5 Science Park, New Haven, CT, United States, 06511
IndustryBiotechnology
CEODr. Randy Teel Ph.D.
E-voting on sharesClick here to vote

Key Management of Arvinas Inc.

Name

Title

Mr. Jared M. Freedberg J.D.

General Counsel & Corporate Secretary

Mr. Paul McInulty

Senior Vice President of Regulatory Affairs

Mr. David K. Loomis M.B.A.

VP & Chief Accounting Officer

Mr. Jeff Boyle

Vice President of Investor Relations

Dr. Randy Teel Ph.D.

CEO, President & Director

Mr. Steve Weiss

Senior VP & Chief Human Resources Officer

Ms. Kelly Page

Senior VP & Global Head of Oncology Strategy and Program Leadership

Mr. Andrew R. Saik

CFO & Treasurer

Ms. Angela M. Cacace Ph.D.

Chief Scientific Officer

FAQs

What is Arvinas Inc. share price today?

Arvinas Inc. share price today is $8.03 as on at the close of the market. Arvinas Inc. share today touched a day high of $8.17 and a low of $7.89.

What is the 52 week high and 52 week low for Arvinas Inc. share?

Arvinas Inc. share touched a 52 week high of $14.51 on and a 52 week low of $6.06 on . Arvinas Inc. stock price today i.e. is closed at $8.03,which is 44.66% down from its 52 week high and 32.62% up from its 52 week low.

What is Arvinas Inc.'s market capitalisation today?

Arvinas Inc. market capitalisation is $0.00T as on .

How to invest in Arvinas Inc. Stock (ARVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arvinas Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arvinas Inc. Shares that will get you 0.1868 shares as per Arvinas Inc. share price of $8.03 per share as on August 1, 2026 at 8:45 am IST.

What is the minimum amount required to buy Arvinas Inc. Stock (ARVN) from India?

Indian investors can start investing in Arvinas Inc. (ARVN) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Arvinas Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Arvinas Inc. share’s latest price of $8.03 as on August 1, 2026 at 8:45 am IST, you will get 1.2453 shares of Arvinas Inc.. Learn more about fractional shares .

What are the returns that Arvinas Inc. has given to Indian investors in the last 5 years?

Arvinas Inc. stock has given -92.06% share price returns and 28.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?